Poggio, E. D., Augustine, J. J., Arrigain, S., Brennan, D. C. & Schold, J. D. Long-term kidney transplant graft survival-making progress when most needed. Am. J. Transpl. 21, 2824–2832 (2021).
Van Loon, E. et al. Assessing the complex causes of kidney allograft loss. Transplantation 104, 2557–2566 (2020).
Mayrdorfer, M. et al. Exploring the complexity of death-censored kidney allograft failure. J. Am. Soc. Nephrol. 32, 1513–1526 (2021).
D’Agati, V. D. et al. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat. Rev. Nephrol. 12, 453–471 (2016).
D’Costa, M. R. et al. Chronic histologic changes are present regardless of HLA mismatches: evidence from HLA-identical living donor kidney transplants. Transplantation 105, e244–e256 (2021).
de Vries, A. P. J. et al. Insulin resistance as putative cause of chronic renal transplant dysfunction. Am. J. Kidney Dis. 41, 859–867 (2003).
Halloran, P. F., Madill-Thomsen, K. S. & Reeve, J. The molecular phenotype of kidney transplants: insights from the MMDx project. Transplantation 108, 45–71 (2024).
Madill-Thomsen, K. et al. Discrepancy analysis comparing molecular and histology diagnoses in kidney transplant biopsies. Am. J. Transplant. 20, 1341–1350 (2020).
Loupy, A., Mengel, M. & Haas, M. Thirty years of the International Banff Classification for Allograft Pathology: the past, present, and future of kidney transplant diagnostics. Kidney Int. 101, 678–691 (2022).
Callemeyn, J. et al. Allorecognition and the spectrum of kidney transplant rejection. Kidney Int. 101, 692–710 (2022).
Harden, P. N. et al. Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients. Am. J. Transpl. 21, 1603–1611 (2021).
Williams, C. G., Lee, H. J., Asatsuma, T., Vento-Tormo, R. & Haque, A. An introduction to spatial transcriptomics for biomedical research. Genome Med. 14, 68 (2022).
Lamarthée, B. et al. Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection. Nat. Commun. 14, 4359 (2023).
Loupy, A. et al. Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study. BMJ 366, 4923 (2019).
Raynaud, M. et al. Dynamic prediction of renal survival among deeply phenotyped kidney transplant recipients using artificial intelligence: an observational, international, multicohort study. Lancet Digital Health 3, e795–e805 (2021).
Zwart, T. C. et al. Volumetric microsampling for simultaneous remote immunosuppressant and kidney function monitoring in outpatient kidney transplant recipients. Br. J. Clin. Pharmacol. 88, 4854–4869 (2022).
Davis, S. et al. Adequate tacrolimus exposure modulates the impact of HLA class II molecular mismatch: a validation study in an American cohort. Am. J. Transpl. 21, 322–328 (2021).
Meziyerh, S. et al. Tacrolimus and mycophenolic acid exposure are associated with biopsy-proven acute rejection: a study to provide evidence for longer-term target ranges. Clin. Pharmacol. Ther. 114, 192–200 (2023).
Gold, A., Tönshoff, B., Döhler, B. & Süsal, C. Association of graft survival with tacrolimus exposure and late intra-patient tacrolimus variability in pediatric and young adult renal transplant recipients — an international CTS registry analysis. Transpl. Int. 33, 1681–1692 (2020).
van den Broek, D. A. J. et al. The clinical utility of post-transplant monitoring of donor-specific antibodies in stable renal transplant recipients: a consensus report with guideline statements for clinical practice. Transpl. Int. 36, 11321 (2023).
Doberer, K. et al. Torque teno virus load is associated with subclinical alloreactivity in kidney transplant recipients: a prospective observational trial. Transplantation 105, 2112–2118 (2021).
Park, S. et al. European Society of Organ Transplantation consensus statement on testing for non-invasive diagnosis of kidney allograft rejection. Transpl. Int. 36, 12115 (2024).
Van Loon, E. et al. Automated urinary chemokine assays for noninvasive detection of kidney transplant rejection: a prospective cohort study. Am. J. Kidney Dis. 83, 467–476 (2023).
Nankivell, B. J. et al. The natural history of chronic allograft nephropathy. N. Engl. J. Med. 349, 2326–2333 (2003).
Kataria, A., Kumar, D. & Gupta, G. Donor-derived cell-free DNA in solid-organ transplant diagnostics: indications, limitations, and future directions. Transplantation 105, 1203–1211 (2021).
Eckardt, K.-U., Kasiske, B. L. & Zeier, M. G. Special issue: KDIGO clinical practice guideline for the care of kidney transplant recipients. Am. J. Transpl. 9, s1–s155 (2009).
Bloom, R. D. & Augustine, J. J. Beyond the biopsy: monitoring immune status in kidney recipients. Clin. J. Am. Soc. Nephrol. 16, 1413–1422 (2021).
Naesens, M. et al. The Banff 2022 Kidney Meeting report: reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics. Am. J. Transpl. 24, 338–349 (2023).
Louis, D. N. et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 23, 1231–1251 (2021).
Roufosse, C. et al. The Banff 2022 Kidney Meeting work plan: data-driven refinement of the Banff Classification for renal allografts. Am. J. Transplant. 24, 350–361 (2023).
Haas, M. et al. The Banff 2017 Kidney Meeting report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. Am. J. Transplant. 18, 293–307 (2018).
Yoo, D. et al. An automated histological classification system for precision diagnostics of kidney allografts. Nat. Med. 29, 1211–1220 (2023).
Hermsen, M. et al. Deep learning-based histopathologic assessment of kidney tissue. J. Am. Soc. Nephrol. 30, 1968–1979 (2019).
Farris, A. B. et al. Banff Digital Pathology working group: image bank, artificial intelligence algorithm, and challenge trial developments. Transpl. Int. 36, 11783 (2023).
Kers, J. et al. Deep learning-based classification of kidney transplant pathology: a retrospective, multicentre, proof-of-concept study. Lancet Digital Health 4, e18–e26 (2022).
Cristoferi, I. et al. Multiomic profiling of transplant glomerulopathy reveals a novel T-cell dominant subclass. Kidney Int. 105, 812–823 (2024).
Sellarés, J. et al. Molecular diagnosis of antibody-mediated rejection in human kidney transplants. Am. J. Transpl. 13, 971–983 (2013).
Halloran, P. F. et al. Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM). Am. J. Transpl. 13, 2865–2874 (2013).
Reeve, J. et al. Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies. Am. J. Transpl. 13, 645–655 (2013).
Reeve, J. et al. Generating automated kidney transplant biopsy reports combining molecular measurements with ensembles of machine learning classifiers. Am. J. Transpl. 19, 2719–2731 (2019).
Jaksik, R., Iwanaszko, M., Rzeszowska-Wolny, J. & Kimmel, M. Microarray experiments and factors which affect their reliability. Biol. Direct 10, 46 (2015).
Loupy, A. et al. The Banff 2019 Kidney Meeting Report (I): updates on and clarification of criteria for T cell- and antibody-mediated rejection. Am. J. Transpl. 20, 2318–2331 (2020).
Hidalgo, L. G. et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am. J. Transpl. 10, 1812–1822 (2010).
Yazdani, S. et al. Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation. Kidney Int. 95, 188–198 (2019).
Xinmin, L. & Cun-Yu, W. From bulk, single-cell to spatial RNA sequencing. Int. J. Oral. Sci. 13, 36 (2021).
Zhang, Y. et al. Single‐cell RNA sequencing in cancer research. J. Exp. Clin. Cancer Res. 40, 81 (2021).
Kuppe, C., Perales-Patón, J., Saez-Rodriguez, J. & Kramann, R. Experimental and computational technologies to dissect the kidney at the single-cell level. Nephrol. Dial. Transpl. 37, 628–637 (2022).
Wu, H. et al. Single-cell transcriptomics of a human kidney allograft biopsy specimen defines a diverse inflammatory response. J. Am. Soc. Nephrol. 29, 2069–2080 (2018).
Wilson, P. C. et al. The single-cell transcriptomic landscape of early human diabetic nephropathy. Proc. Natl Acad. Sci. USA 116, 19619–19625 (2019).
do Valle Duraes, F. et al. Immune cell landscaping reveals a protective role for regulatory T cells during kidney injury and fibrosis. JCI Insight 5, e130651 (2020).
Subramanian, A. et al. Single cell census of human kidney organoids shows reproducibility and diminished off-target cells after transplantation. Nat. Commun. 10, 5462 (2019).
Stewart, B. J., Ferdinand, J. R. & Clatworthy, M. R. Using single-cell technologies to map the human immune system — implications for nephrology. Nat. Rev. Nephrol. 16, 112–128 (2020).
Liao, J. et al. Single-cell RNA sequencing of human kidney. Sci. Data 7, 4 (2020).
Malone, A. F. & Humphreys, B. D. Single-cell transcriptomics and solid organ transplantation. Transplantation 103, 1776–1782 (2019).
Zheng, G. X. Y. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).
Dimitrov, D. et al. Comparison of methods and resources for cell-cell communication inference from single-cell RNA-Seq data. Nat. Commun. 13, 3224 (2022).
Yang, W. et al. DeepCCI: a deep learning framework for identifying cell–cell interactions from single-cell RNA sequencing data. Bioinformatics 39, btad596 (2023).
Leckie-Harre, A., Silverman, I., Wu, H., Humphreys, B. D. & Malone, A. F. Sequencing of physically interacting cells in human kidney allograft rejection to infer contact-dependent immune cell transcription. Transplantation 108, 421–429 (2024).
Shakoori, A. R. in Chromosome Structure and Aberrations (eds Bhat, T., Wani, A.) 343–367 https://doi.org/10.1007/978-81-322-3673-3_16 (Springer, 2017).
Chen, K. H., Boettiger, A. N., Moffitt, J. R., Wang, S. & Zhuang, X. RNA imaging. Spatially resolved, highly multiplexed RNA profiling in single cells. Science 348, aaa6090 (2015).
He, S. et al. High-plex imaging of RNA and proteins at subcellular resolution in fixed tissue by spatial molecular imaging. Nat. Biotechnol. 40, 1794–1806 (2022).
Janesick, A. et al. High resolution mapping of the tumor microenvironment using integrated single-cell, spatial and in situ analysis. Nat. Commun. 14, 8353 (2023).
Wang, Y. et al. Spatial transcriptomics: technologies, applications and experimental considerations. Genomics 115, 110671 (2023).
Zhang, L. et al. Clinical and translational values of spatial transcriptomics. Signal. Transduct. Target. Ther. 7, 111 (2022).
Chen, A. et al. Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays. Cell 185, 1777–1792.e21 (2022).
Liu, X. et al. Clinical challenges of tissue preparation for spatial transcriptome. Clin. Transl. Med. 12, e669 (2022).
Asp, M., Bergenstråhle, J. & Lundeberg, J. Spatially resolved transcriptomes — next generation tools for tissue exploration. BioEssays 42, e1900221 (2020).
Pour, M. & Yanai, I. New adventures in spatial transcriptomics. Dev. Cell 57, 1209–1210 (2022).
Slavov, N. Learning from natural variation across the proteomes of single cells. PLoS Biol. 20, e3001512 (2022).
Verma, S. K. & Molitoris, B. A. Renal endothelial injury and microvascular dysfunction in acute kidney injury. Semin. Nephrol. 35, 96–107 (2015).
Colombo, S. et al. Phospholipidome of endothelial cells shows a different adaptation response upon oxidative, glycative and lipoxidative stress. Sci. Rep. 8, 12365 (2018).
Dumas, S. J. et al. Phenotypic diversity and metabolic specialization of renal endothelial cells. Nat. Rev. Nephrol. 17, 441–464 (2021).
Marcu, R. et al. Human organ-specific endothelial cell heterogeneity. iScience 4, 20–35 (2018).
Nolan, D. J. et al. Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration. Dev. Cell 26, 204–219 (2013).
Dumas, S. J. et al. Single-cell RNA sequencing reveals renal endothelium heterogeneity and metabolic adaptation to water deprivation. J. Am. Soc. Nephrol. 31, 118–138 (2020).
Bancroft J., S. A. e., The Theory and Practice of Histological Techniques. 2nd ed. (Longman Group Limited, 1982).
Sheng, W. et al. Multiplex immunofluorescence: a powerful tool. cancer immunotherapy. Int. J. Mol. Sci. 24, 3086 (2023).
Tan, W. C. C. et al. Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy. Cancer Commun. 40, 135–153 (2020).
Bosisio, F. M. et al. Next-generation pathology using multiplexed immunohistochemistry: mapping tissue architecture at single-cell level. Front. Oncol. 12, 918900 (2022).
Giesen, C. et al. Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat. Methods 11, 417–422 (2014).
Schapiro, D. et al. HistoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data. Nat. Methods 14, 873–876 (2017).
Le Rochais, M., Hemon, P., Pers, J.-O. & Uguen, A. Application of high-throughput imaging mass cytometry hyperion in cancer research. Front. Immunol. 13, 859414 (2022).
Hickey, J. W., Tan, Y., Nolan, G. P. & Goltsev, Y. Strategies for accurate cell type identification in CODEX multiplexed imaging data. Front. Immunol. 12, 727626 (2021).
Lin, J.-R., Fallahi-Sichani, M., Chen, J.-Y. & Sorger, P. K. Cyclic immunofluorescence (CycIF), a highly multiplexed method for single-cell imaging. Curr. Protoc. Chem. Biol. 8, 251–264 (2016).
Kennedy-Darling, J. et al. Highly multiplexed tissue imaging using repeated oligonucleotide exchange reaction. Eur. J. Immunol. 51, 1262–1277 (2021).
Goltsev, Y. et al. Deep profiling of mouse splenic architecture with CODEX multiplexed imaging. Cell 174, 968–981.e15 (2018).
Calvani, J. et al. In situ multiplex immunofluorescence analysis of the inflammatory burden in kidney allograft rejection: a new tool to characterize the alloimmune response. Am. J. Transpl. 20, 942–953 (2020).
Kim, M.-S. et al. Multiplex immunofluorescence assay of infiltrating mononuclear cell subsets in acute T-cell-mediated rejection and BK virus-associated nephropathy in the allograft kidney. Diagnostics 12, 268 (2022).
Neumann, E. K. et al. Highly multiplexed immunofluorescence of the human kidney using co-detection by indexing. Kidney Int. 101, 137–143 (2022).
Alexander, M. P. et al. Exploring the single-cell immune landscape of kidney allograft inflammation using imaging mass cytometry. Am. J. Transpl. 24, 549–563 (2023).
Zhu, X., Xu, T., Peng, C. & We, S. Advances in MALDI mass spectrometry imaging single cell and tissues. Front. Chem. 9, 782432 (2022).
Unsihuay, D., Mesa Sanchez, D. & Laskin, J. Quantitative mass spectrometry imaging of biological systems. Annu. Rev. Phys. Chem. 72, 307–329 (2021).
Baquer, G. et al. What are we imaging? Software tools and experimental strategies for annotation and identification of small molecules in mass spectrometry imaging. Mass. Spectrom. Rev. 42, 1927–1964 (2023).
Denti, V. et al. Antigen retrieval and its effect on the MALDI-MSI of lipids in formalin-fixed paraffin-embedded tissue. J. Am. Soc. Mass. Spectrom. 31, 1619–1624 (2020).
Argelaguet, R., Cuomo, A. S. E., Stegle, O. & Marioni, J. C. Computational principles and challenges in single-cell data integration. Nat. Biotechnol. 39, 1202–1215 (2021).
Ma, A., McDermaid, A., Xu, J., Chang, Y. & Ma, Q. Integrative methods and practical challenges for single-cell multi-omics. Trends Biotechnol. 38, 1007–1022 (2020).
Vandereyken, K., Sifrim, A., Thienpont, B. & Voet, T. Methods and applications for single-cell and spatial multi-omics. Nat. Rev. Genet. 24, 494–515 (2023).
Bergenstråhle, L. et al. Super-resolved spatial transcriptomics by deep data fusion. Nat. Biotechnol. 40, 476–479 (2022).
Efremova, M. & Teichmann, S. A. Computational methods for single-cell omics across modalities. Nat. Methods 17, 14–17 (2020).
Kleino, I., Frolovaitė, P., Suomi, T. & Elo, L. L. Computational solutions for spatial transcriptomics. Comput. Struct. Biotechnol. J. 20, 4870–4884 (2022).
Lipkova, J. et al. Artificial intelligence for multimodal data integration in oncology. Cancer Cell 40, 1095–1110 (2022).
Chen, R. J. et al. Pathomic fusion: an integrated framework for fusing histopathology and genomic features for cancer diagnosis and prognosis. IEEE Trans. Med. Imaging 41, 757–770 (2022).
Zhang, D. et al. Inferring super-resolution tissue architecture by integrating spatial transcriptomics with histology. Nat. Biotechnol. 25, bbae052 (2024).
Suo, L., Murillo, M. C., Gallay, B. & Hod-Dvorai, R. Discrepancy analysis between histology and molecular diagnoses in kidney allograft biopsies: a single-center experience. Int. J. Mol. Sci. 24, 13817 (2023).
Kaya, I. et al. Histology-compatible MALDI mass spectrometry based imaging of neuronal lipids for subsequent immunofluorescent staining. Anal. Chem. 89, 4685–4694 (2017).
Wang, G. et al. Analyzing cell-type-specific dynamics of metabolism in kidney repair. Nat. Metab. 4, 1109–1118 (2022).
Vicari, M. et al., Spatial multimodal analysis of transcriptomes and metabolomes in tissues. Nat. Biotechnol. https://doi.org/10.1038/s41587-023-01937-y (2023).
Dunne, J. et al. Evaluation of antibody-based single cell type imaging techniques coupled to multiplexed imaging of N-glycans and collagen peptides by matrix-assisted laser desorption/ionization mass spectrometry imaging. Anal. Bioanal. Chem. 415, 7011–7024 (2023).
El-Achkar, T. M. et al. A multimodal and integrated approach to interrogate human kidney biopsies with rigor and reproducibility: guidelines from the Kidney Precision Medicine Project. Physiol. Genomics 53, 1–11 (2021).
Salem, F. et al. The spatially resolved transcriptional profile of acute T cell-mediated rejection in a kidney allograft. Kidney Int. 101, 131–136 (2022).
Rietjens, R. et al. FC 120: lipid changes as early indicator for diabetes induced renal pathology. Nephrol. Dial. Transpl. 37, gfac125.002 (2022).
Moore, J. L., Patterson, N. H., Norris, J. L. & Caprioli, R. M. Prospective on imaging mass spectrometry in clinical diagnostics. Mol. Cell. Proteom. 22, 100576 (2023).
Stella, M. et al. Histology-guided proteomic analysis to investigate the molecular profiles of clear cell renal cell carcinoma grades. J. Proteom. 191, 38–47 (2019).
Kriegsmann, M. et al. Mass spectrometry imaging differentiates chromophobe renal cell carcinoma and renal oncocytoma with high accuracy. J. Cancer 11, 6081–6089 (2020).
Möginger, U., Marcussen, N. & Jensen, O. N. Histo-molecular differentiation of renal cancer subtypes by mass spectrometry imaging and rapid proteome profiling of formalin-fixed paraffin-embedded tumor tissue sections. Oncotarget 11, 3998–4015 (2020).
Nizioł, J. et al. Localization of metabolites of human kidney tissue with infrared laser-based selected reaction monitoring mass spectrometry imaging and silver-109 nanoparticle-based surface assisted laser desorption/ionization mass spectrometry imaging. Anal. Chem. 92, 4251–4258 (2020).
Zhang, J., Li, S. Q., Lin, J. Q., Yu, W. & Eberlin, L. S. Mass spectrometry imaging enables discrimination of renal oncocytoma from renal cell cancer subtypes and normal kidney tissues. Cancer Res. 80, 689–698 (2020).
Erlmeier, F. et al. MALDI mass spectrometry imaging — prognostic pathways and metabolites for renal cell carcinomas. Cancers 14, 1763 (2022).
Oppenheimer, S. R., Mi, D., Sanders, M. E. & Caprioli, R. M. Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma. J. Proteome Res. 9, 2182–2190 (2010).
Grove, K. J. et al. Diabetic nephropathy induces alterations in the glomerular and tubule lipid profiles. J. Lipid Res. 55, 1375–1385 (2014).
Smith, A. et al. Detecting proteomic indicators to distinguish diabetic nephropathy from hypertensive nephrosclerosis by integrating matrix-assisted laser desorption/ionization mass spectrometry imaging with high-mass accuracy mass spectrometry. Kidney Blood Press. Res. 45, 233–248 (2020).
Wang, Z. et al. Spatial-resolved metabolomics reveals tissue-specific metabolic reprogramming in diabetic nephropathy by using mass spectrometry imaging. Acta Pharm. Sin. B 11, 3665–3677 (2021).
Rietjens, R. G. J. et al. Phosphatidylinositol metabolism of the renal proximal tubule S3 segment is disturbed in response to diabetes. Sci. Rep. 13, 6261 (2023).
van Smaalen, T. C. et al. Rapid identification of ischemic injury in renal tissue by mass-spectrometry imaging. Anal. Chem. 91, 3575–3581 (2019).
Rao, S. et al. Early lipid changes in acute kidney injury using SWATH lipidomics coupled with MALDI tissue imaging. Am. J. Physiol. Renal Physiol. 310, F1136–F1147 (2016).
Abdelmoula, W. M. et al. massNet: integrated processing and classification of spatially resolved mass spectrometry data using deep learning for rapid tumor delineation. Bioinformatics 38, 2015–2021 (2022).
Ly, A. et al. Site‐to‐site reproducibility and spatial resolution in MALDI–MSI of peptides from formalin‐fixed paraffin‐embedded samples. Proteom. Clin. Appl. 13, e1800029 (2019).
Boskamp, T. et al. Cross-normalization of MALDI mass spectrometry imaging data improves site-to-site reproducibility. Anal. Chem. 93, 10584–10592 (2021).
Denti, V. et al. Reproducible lipid alterations in patient-derived breast cancer xenograft FFPE tissue identified with MALDI MSI for pre-clinical and clinical application. Metabolites 11, 577 (2021).
Alexandrov, T. Spatial metabolomics and imaging mass spectrometry in the age of artificial intelligence. Annu. Rev. Biomed. Data Sci. 3, 61–87 (2020).
- The Renal Warrior Project. Join Now
- Source: https://www.nature.com/articles/s41581-024-00861-x